Bayer/IVCC extend public health deal
Bayer CropScience has agreed a three-year extension to its deal with the not-for-profit UK vector control company, Innovative Vector Control Consortium (IVCC – Liverpool, Merseyside) to develop active ingredients for use against mosquitoes for malaria and dengue fever control. The companies started working together in 2009 ( Agrow No 568, p 3). Bayer is providing its “library of substances and screening capabilities as well as extensive experience in chemical synthesis, and insecticides research and development”. IVCC chief operating officer Dr Tom McLean welcomes the deal as providing access to the “profound expertise” of the agrochemical industry. He adds that resistance to products is one of the greatest problems in the battle against malaria. IVCC has similar deals with Syngenta and US pharmaceutical company Scynexis ( Agrow No 620, p 2).